medigraphic.com

2015, Number 5

<< Back Next >>

Rev Clin Esc Med 2015; 5 (5)

Actualización en bronquiectasias

Acón RE, Rodríguez SO

Language: Spanish
References: 22
Page: 45-51
PDF size: 829.02 Kb.


ABSTRACT

Bronchiectasis is the pathologic definition of irreversibly dilated bronchi and reflects the final common pathway of a variety of underlying diseases and unrelated pulmonary insults. It is a relatively uncommon but devastating disease associated with high morbidity and mortality. Multiple conditions, congenital or acquired predispose to bronchiectasis, disease that usually presents with chronic cough and daily viscid sputum production. Demographic data, laboratory results, associated symptoms and imaging findings guide the diagnosis and direct the suspicion to certain etiologies. The main goal of the treatment is to limit the cycle of infection and inflammation and, therefore, to reduce the air-way damage, chronic symptoms, number of exacerbations and finally to improve quality of life.


REFERENCES

  1. Vendrell M De Gracia J Olveira C et al. Diagnóstico y Tratamiento de las Bronquiectasias. Arch Bronconeumol. 2008; 44 (11): 629-40.

  2. Oliva I Cortopassi F Herzog E et al. Clinical and Imaging Features of Bronchiectasis. Clin Pulm Med 2013; 20: 203-213.

  3. Weycker D Eldesberg J Oster G Tino G. Prevalence and Economic burden of bronchiectasis. Clin Pulm Med 2005; 12:205.

  4. Mc Donnell M Hester K De Soyza A. Bronchiectasis: Clinical Features and Management with a Focus on Inhaled Antibiotics. Clin Pulm Med 2014; 21: 251-261.

  5. Barker AF. Bronchiectasis. N Engl J Med 2002; 346:1383.

  6. Chalmers JD Hill AT. Mechanisms of immune dysfunction and bacterial persistence in noncystic fibrosis bronchiectasis. Mol Immunol 2013; 55:27.

  7. Barberà JA Cosío MG. Bronquiectasias y otras enfermedades obstructivas de las vías aéreas. En: Farreras Valentí P, Rozman C, ed. Medicina interna. Edición 14a. Madrid: Hardcourt: 2000: vol 1: 860-869.

  8. Chalmers JD McHugh BJ Docherty C et al. Vitamin D deficiency is associated with chronic bacterial colonisation and disease severity in bronchiectasis. Thorax 2013; 68:39.

  9. King PT Holdsworth SR Freezer NJ et al. Characterisation of the onset and presenting clinical features of adult bronchiectasis. Respir Med 2006; 100: 2183.

  10. Bienvenu T Sermet-Gaudelus I Burgel PR et al. Cystic Fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 2010; 181:1078.

  11. Van de ven AA van Montfrans JM Terheggen- Lagro SW et al. A CT scan score for the assessment of lung disease in children with common variable immunodeficiency disorders. Chest 2010; 138:371.

  12. Vendrell M De Gracia J Rodrigo MJ et al. Antibody production deficiency with normal IgG levels in bronchiectasis of unknown etiology. Chest 2005; 127:197.

  13. Goeminne P Dupont L. Non-cystic fibrosis bronquiectasis: diagnosis and management in 21st century. Postgrad Med J. 2010; 86:493-501.

  14. Gotaway M Gautham P Webb R et al. High- Resolution CT of the Lung: Patterns of Disease and Differential Diagnoses.

  15. Kim RD Greenberg DE Ehrmantraut ME et al. Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am J Respir Crit Care Med 2008; 178:1066.

  16. Rowan SA Bradley JM Bradbury I et al. Lung clearance index is a repeatable and sensitive indicator of radiological changes in bronchiectasis. Am J Respir Crit Care Med 2014; 189:586.

  17. Feldman C. Bronchiectasis: new approaches to diagnosis and management. Clin Chest Med. 2011; 32: 535-546.

  18. Li AM Sonnappa S Lex C et al. Non-CF bronchiectasis: does knowing the aetiology lead to changes in management? Eur Respir J. 2005; 26:8-14.

  19. Lucas M Lee M Lortan J et al. Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. J Allergy Clin Immunol 2010; 125:1354.

  20. Gao Y Guan W Xu G et al. The role of viral infection in pulmonary exacerbations of bronchiectasis in adults: A prospective study. Chest 2014.

  21. Pasteur MC Bilton D Hill AT. British Thoracic Society Bronchiectasis non-CF Guideline Group. British Thoracic Society Guideline for non-CF bronquiectasis. Thorax 2010;65 Suppl1:11-

  22. Murray MP Turnbull K Macquire S Hill AT. Assessing response to treatment of exacerbations of bronchiectasis in adults. Eur Respir J 2009; 33:312.




2020     |     www.medigraphic.com